Do Implementation Intentions Increase Average Daily Step Count.
Pedometer Program:Every Step Counts
1 other identifier
interventional
280
1 country
1
Brief Summary
Cardiovascular disease is the second major cause of death for women in Israel and the leading cause of death among women worldwide. Women have higher mortality rates after a coronary or cerebrovascular event compared to men, and receive less attention for prevention and treatment of heart disease. The risk factors for heart disease among women in Israel are high: 53% of women in the State of Israel are overweight or obese and 48% of women do not exercise. Increasing physical activity can lower the risk of developing cardiovascular disease in women. The literature suggests that even minor changes in behavior can reduce the morbidity, mortality and costs to the health care system. Pedometers have proven to be an effective tool for increasing physical activity, and have the potential to create change in health habits. The pedometer measures steps and is a simple measure that gives an estimate of the extent of exercise in terms of steps. The device is simple and user-friendly and serves as an indicator of movement as a result of health choices. The literature shows that when pedometers are integrated into a support program, they provide an incentive to increase physical activity. Supporting software includes, among other things - choosing personal goals, close tracking, and self-tracking and re balancing systems. "Implementation intention" is a strategy in the form of an "if-then plan" that can increase the likelihood of attaining one's goals. It is different than specifying a goal intentions as it specifies the when, where and how portions of goal-directed behavior. This study seeks to compare the increase in steps in participants randomly assigned in a 2:2:1 allocation to a goal-setting pedometer intervention, a goal-setting plus implementation intentions pedometer intervention vs pedometer only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 21, 2014
CompletedFirst Submitted
Initial submission to the registry
December 4, 2019
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedApril 25, 2023
April 1, 2023
9.2 years
December 4, 2019
April 23, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Step count
Average step count over 5 days of the last week of participation in the protocol
13 weeks
Secondary Outcomes (7)
Blood pressure
13 weeks
Body mass index
13 weeks
waist circumference
13 weeks
Percentage increase in steps
13 weeks
self report of burnout
13 weeks
- +2 more secondary outcomes
Study Arms (3)
Pedometer only
PLACEBO COMPARATORparticipants will be given a pedometer and instructed how to use it, but will not participate in the goal setting intervention.
Pedometer and intervention
ACTIVE COMPARATORparticipants will be given a pedometer and participate in a weekly goal setting meeting with the investigator and will receive weekly tips.
Pedometer, intervention and implementation intentions
EXPERIMENTALparticipants will be given a pedometer and participate in the weekly goal setting as above. In addition, 3 times during the intervention they will fill out a form that encourages performance of implementation intentions.
Interventions
The participant will meet weekly with the investigator, report steps and set goals for the following week.
In addition to the standard goal-setting intervention, the participant will fill out a form that directs them to perform implementation intentions at weeks 1, 5 and 9.
the participant will be given a pedometer and instructed how to use it.
Eligibility Criteria
You may qualify if:
- Hadassah employees, volunteers and retirees
- able to commit to 12 week program
- no medical contraindication to physical activity
You may not qualify if:
- unable to walk
- unable to maintain and use the pedometer
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Donna R Zwas, MD MPH
Hadassah Medical Organization
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Cardiologist
Study Record Dates
First Submitted
December 4, 2019
First Posted
February 6, 2020
Study Start
October 21, 2014
Primary Completion
January 1, 2024
Study Completion
March 30, 2024
Last Updated
April 25, 2023
Record last verified: 2023-04